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Clinical outcomes such as survival and recurrence, and clinician-reported outcomes including 
measures of patient function like the Barthel Index, have an important role in assessing effects of 
treatment and disease at both individual and population level. However, they do not capture 
patients’ perspective of the consequences of disease on functional status, well-being, health-related 
quality of life, or symptom burden.(1) Patient Reported Outcome Measures (PROMs) questionnaires, 
completed by patients, provide a quantitative measure of patients’ own experience of their health, 
including burden of disease and effects of treatments or interventions.(1) Broadly, PROMs are 
categorised as generic (such as the Short-Form-36) or condition-specific (such as the Stroke-Specific 
Quality of Life Scale) (Table 1). Ideally, patients should participate in all stages of PROM development 
– both as research partners and participants to ensure relevance and acceptability.(2) However, 
many PROMs are developed without patient input.(3) In this issue of NEUROLOGY, Saigle et al. 
report a scoping review of patient, family, and carer input into the development of PROMs for 
subarachnoid hemorrhage (SAH).(4) They include studies that incorporate patient, family, and carer 
perspectives on priorities for SAH-specific PROM content, co-development, and evaluation.  
 
The authors identified 12 (distinct) relevant articles that included 879 patients with SAH and 241 
carers. The systematic and comprehensive search strategy alongside robust methodology, including 
independent screening by two reviewers, represent key strengths of the review. The failure to 
include relevant grey (non-academic) literature, such as the priority setting haemorrhagic stroke 
workshop completed by the Stroke Association (UK charity) in 2014, constitutes a limitation of their 
approach.(5) 
 
The majority of studies identified by the review described symptoms or outcomes ‘spontaneously’ 
reported by participants. However, none of the studies attempted to establish those most important 
to participants. Only two PROMs involved SAH patients or their carers in the development: the 
Wessex Patient Carer Questionnaire (WPCQ) and the Subarachnoid Hemorrhage Outcome Tool 
(SAHOT). In addition, one study evaluated the relevance of a pre-existing PROM, the Functional 
Status Examination (FSE) to SAH survivors. None of these PROMs included patient/ carer 
involvement at all stages of PROM development and evaluation, and most underreported or 
provided non-specific details about patient/carer involvement. 
  
This review focuses specifically on SAH survivors and carers – stakeholders frequently excluded from 
stroke outcomes research.(6) It highlights the lack of knowledge regarding those symptoms and 
outcomes that are most important to these patients and their carers. The recently developed 
International Standard Set of PROMs after stroke explicitly excluded SAH due to differences in 
treatment and outcomes.(6) Furthermore,  PROMs have had limited use to date in SAH randomised 
controlled trials. A systematic review found patient-reported quality of life measures reported in 
only 8.5% (11/129) of studies and all were generic PROMs.(7) The review by Saigle et al highlights 
the need for greater involvement of patients and carers in the development and evaluation of SAH 
PROMs, and the importance of wider implementation of PROMs in SAH research and clinical care. 
 
PROMs provide a method to capture patients’ perspectives and can be integrated into clinical care 
to support communication between patients and clinicians, facilitate shared decision making, and 
monitor adverse events.(1) At an aggregate level, PROMs have potential to inform service delivery 
and commissioning.(1)  However, they require comprehensive patient involvement in design and 
evaluation to ensure they represent factors patients believe important, and to increase the 
likelihood patients will complete them. The increased drive for patient-centred healthcare, shared-
decision making, and involvement of patients in co-production of research should extend to SAH. 
SAH research capturing relevant and patient focused outcome measures will help achieve this goal. 
The hundreds of different generic and condition-specific PROMs available create difficulties for 
clinicians deciding which PROM(s) to select for clinical practice. In consultation with key 
stakeholders, including patients, families, researchers, clinicians, allied health workers and policy-
makers, the COMET (Core Outcome Measures in Effectiveness Trials) Initiative is developing a Core 
Outcomes Set for SAH clinical research (2016-2020).(8) This Core Outcomes Set will provide a 
valuable resource in the future to provide recommendations for standardised outcomes (clinical, 
clinician-reported and patient-reported) for this population. However, it will not recommend which 
instrument to use to measure the outcomes. Clinicians should consult their patient groups to inform 
decisions regarding the appropriate and meaningful PROM(s). The WPCQ and the SAHOT have been 
developed with input from SAH patients and carers, so may be more acceptable and relevant than 
other stroke-specific or generic PROMs. Other considerations include: psychometric properties, 
rationale for PROM collection, interpretability, resources, and cost. 
 
Successful implementation of PROMs into clinical practice and research requires meaningful and 
easy to interpret PROM data. This requires a ‘bottom-up’ approach whereby patients, carers, 
clinicians, and other key stakeholders actively participate in development, selection, and 
implementation of PROMs. Developers should report this involvement transparently to enable 
quality appraisal and learning for other disciplines. The Saigle et al review provides a useful summary 
of the current involvement of patients in SAH PROMs, but highlights the lack of patient involvement 
in PROM development to date. By doing so, they identify an important area for future SAH research. 
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Table 1: Comparison between generic and condition-specific PROMs.  
Type of PROM Strengths and Limitations Example PROM 
Generic: 
Designed to be 
used in any 
patient 
population  
Strengths:  
-Enable comparison across 
different health problems or 
populations. 
-Useful when there are no 
condition-specific PROMs 
available. 
-Useful for patients with 
multi-morbidities. 
Limitations: 
-May not provide an 
adequate level of detail. 
-Can be less sensitive to 
capturing change. 
Name:  Short Form-36 (SF-36) 
Domains: N=8 
Physical functioning; Role 
limitations-physical; Role 
limitations-emotional; Bodily 
pain; General health; Vitality; 
Social functioning; Mental health 
Questions: N=36  
Example 
question: 
 
In general, would you say your 
health is: 
       a) Excellent  
       b) Very Good  
       c) Good  
       d) Fair  
       e) Poor 
Condition-
specific:  
Developed for a 
particular 
disease, 
condition or 
injury 
Strengths: 
-Specifically measure 
problems or aspects of 
health relevant to the 
condition. 
-Can be more responsive to 
change. 
Limitations: 
-Unable to make 
comparisons with the 
general population or other 
conditions. 
Name:  
 
Stroke-Specific Quality of Life 
Scale (SS-QOL) 
Domains: 
  
N=12 
Energy; Family roles; Language; 
Mobility; Mood; Personality; Self 
care; Social roles; Thinking; Upper 
extremity function; Vison; Work/ 
productivity 
Questions: N=49 
Example 
question: 
It was hard for me to concentrate: 
       1) Strongly agree 
       2) Moderately agree 
       3) Neither agree or disagree 
       4) Moderately disagree 
       5) Strongly disagree 
 
 
 
